James Bohnsack

James C.
Bohnsack serves on the Board of Janus Health Technologies, Inc. He has dedicated his 20+ year career in a variety of leadership roles in the healthcare industry.
His healthcare experience ranges from strategy to process, services to technology and health systems to corporations.
Mr. Bohnsack serves as Chief Strategy Officer for Aspirion, a portfolio company of Linden Capital Partners.
Prior to joining Aspirion, he served as the Chief Revenue & Strategy Officer for TransUnion Healthcare where he was responsible for corporate strategy, mergers & acquisitions, product development and go-to-market functions.
The success at TransUnion resulted in the carve-out and sale of the business to Clearlake Capital and n-Thrive in late 2021.
Prior to returning to TransUnion Healthcare, Mr. Bohnsack held leadership positions at Strivant Health, a Dallas-based physician revenue cycle management company, CIOX Health, a New Mountain Capital portfolio company and Conifer Health Solutions, a subsidiary of Tenet Health.
Earlier in his career, he advised health systems, health plans and physician practices as part of the Strategy & Operations teams at Deloitte and Ernst & Young.
Mr. Bohnsack holds a Bachelor of Science in Business Administration and Master of Science in Healthcare Administration from Trinity University in San Antonio, TX.